EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S — Credit Rating and Financial Key Figures

EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S (CVR number: 29428689K) is a company from SKANDERBORG. The company recorded a gross profit of 65.2 mDKK in 2022. The operating profit was 12.6 mDKK, while net earnings were 9511.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was 23.8 %, which can be considered excellent and Return on Equity (ROE) was 52 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 29.7 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S's liquidity measured by quick ratio was 1.4 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.